Back to Search Start Over

Human epidermal growth factor receptor 2 (HER2) immunoreactivity:specificity of three pharmacodiagnostic antibodies

Authors :
Rasmussen, Anne-Sofie Schrohl
Pedersen, Hans Christian
Jensen, Sussie Steen
Nielsen, Signe Lykke
Brünner, Nils
Rasmussen, Anne-Sofie Schrohl
Pedersen, Hans Christian
Jensen, Sussie Steen
Nielsen, Signe Lykke
Brünner, Nils
Source :
Rasmussen , A-S S , Pedersen , H C , Jensen , S S , Nielsen , S L & Brünner , N 2011 , ' Human epidermal growth factor receptor 2 (HER2) immunoreactivity : specificity of three pharmacodiagnostic antibodies ' , Histopathology , vol. 59 , no. 5 , pp. 975-983 .
Publication Year :
2011

Abstract

The availability of specific antibody-based test systems is essential to testing of HER2 protein expression. Here, we mapped epitopes recognized by three pharmacodiagnostic HER2 antibodies and investigated their specificity towards peptides and fusion proteins homologous to the intracellular domains of HER1, HER2, HER3 and HER4. The investigated antibodies were PATHWAY(®) HER2 (clone 4B5; Ventana Medical Systems Inc., Tucson, AZ, USA), HercepTest™ (Dako Denmark A/S, Glostrup, Denmark), and Oracle(®) HER2 (clone CB11; Leica Microsystems GmbH, Wetzlar, Germany).

Details

Database :
OAIster
Journal :
Rasmussen , A-S S , Pedersen , H C , Jensen , S S , Nielsen , S L & Brünner , N 2011 , ' Human epidermal growth factor receptor 2 (HER2) immunoreactivity : specificity of three pharmacodiagnostic antibodies ' , Histopathology , vol. 59 , no. 5 , pp. 975-983 .
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn826489859
Document Type :
Electronic Resource